WC
GILD icon

Waterloo Capital’s Gilead Sciences GILD Stock Holding History

Waterloo Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$533K Sell
3,823
-1,183
-24% -$166K 0.04% 292
2025
Q4 		$614K Buy
5,006
+1,487
+42% +$181K 0.04% 267
2025
Q3 		$391K Buy
3,519
+345
+11% +$39.2K 0.03% 324
2025
Q2 		$352K Buy
3,174
+793
+33% +$84.4K 0.03% 328
2025
Q1 		$267K Buy
+2,381
New +$246K 0.02% 338

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Waterloo Capital's GILD Position: Q1 2026 in Review

Waterloo Capital reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $166K and leaving 3,823 shares worth $533K. The position accounts for 0.04% of the portfolio, ranked #292.

Waterloo Capital first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $614K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Waterloo Capital held 3,823 shares of Gilead Sciences worth $533K as of Q1 2026.
  • Waterloo Capital sold 1,183 Gilead Sciences shares in Q1 2026, an estimated $166K.
  • Gilead Sciences made up 0.04% of Waterloo Capital's portfolio in Q1 2026, its #292 holding.
  • Waterloo Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Waterloo Capital's Gilead Sciences position peaked at $614K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.